Multiple Sclerosis: Drugs
(asked on 18th November 2014) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment he has made of the ability of people to access Sativex in the NHS.
This question was answered on 21st November 2014
The National Institute for Health and Care Excellence published an updated clinical guideline on the management of multiple sclerosis in primary and secondary care in October 2014, in which Sativex (nabiximols) is not recommended for treating spasticity.
National Health Service commissioners must consider requests to fund Sativex in line with the NHS Constitution.